Looks like stock is being sold below cash backing. The market cap is currently below $80m and thus valuing the pipe at pretty much pre-clinical trial levels.
No value for Relenza, LANI, HRV etc etc. A takeover target?
The big question is when to buy, if at all. Can it fall below 40c? I smell an announcement coming!
Looks like stock is being sold below cash backing. The market...
Add to My Watchlist
What is My Watchlist?